The latest publication by the PROOF Centre indicates that proteo-genomic biomarker ensemble classifiers show promise in the diagnosis of acute rejection in kidney transplant recipients, and can improve classification performance beyond that of individual genomic or proteomic classifiers alone. Click …
Making excellent care for acute heart failure patients a priority through clinical innovation and research
Seven years ago, Andrea Marrie unexpectedly became a heart transplant candidate when she was found teetering at the precipice of end stage heart failure. A healthy and vivacious young woman who was just twenty-two years old, nobody anticipated Andrea to …
IO Informatics Moves into Personalized Medicine with Launch of Healthcare Arm
IO Informatics this week launched a new business arm, dubbed IO Healthcare, that will focus on helping customers in the personalized medicine market use clinical information to enhance their research and development activities. Read more here.…
HTG to Commercialize PROOF’s COPD Risk Stratification Test; Aims for Launch Next Year
Canada’s Prevention of Organ Failure Centre of Excellence has granted HTG Molecular Diagnostics exclusive rights to commercialize a risk stratification test the center has been developing to better personalize treatment for chronic obstructive pulmonary disease. Read more here.…
Signals Intelligence
Four years ago, a team of clinician-scientists led by Bruce McManus, a Professor in the Department of Pathology and Laboratory Medicine, galvanized around a compelling idea – developing definitive and scalable tests to answer questions that now depend on painful, …